Literature DB >> 6459761

Penetration of ocular tissues and fluids by moxalactam in rabbits with staphylococcal endophthalmitis.

A Kane, M Barza, J Baum.   

Abstract

Moxalactam was administered subconjunctivally in 100-mg doses to rabbits with infected eyes (Staphylococcus aureus endophthalmitis). High concentrations of drug were detected in the sclera, cornea, and choroid; much lower levels were found in the retina, whereas peak concentrations in the vitreous were about 6 microgram/ml. Repeated intramuscular injections of 50 mg/kg every 4 h produced peak serum levels of about 100 microgram/ml. A gradient between the choroid and the retina was again evident, and peak vitreous levels were about 6 microgram/ml after six injections. These data are consistent with the concept of a blood-retina barrier analogous to the blood-brain barrier. Moxalactam appears to penetrate the eye somewhat better than do other beta-lactams; however, the peak levels produced in the vitreous humor in this animal model were below the level required to inhibit most strains of Pseudomonas aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6459761      PMCID: PMC181758          DOI: 10.1128/AAC.20.5.595

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Dissecting ocular tissue for intraocular drug studies.

Authors:  R Abel; G L Boyle
Journal:  Invest Ophthalmol       Date:  1976-03

2.  Corneal distribution of subconjunctival antibiotics.

Authors:  D E Oakley; R D Weeks; P P Ellis
Journal:  Am J Ophthalmol       Date:  1976-03       Impact factor: 5.258

3.  A collagenase digestion method for bioassay of antibiotics in ocular tissues.

Authors:  M Barza; A Kane; J Baum
Journal:  Am J Ophthalmol       Date:  1978-07       Impact factor: 5.258

4.  Regional differences in ocular concentration of gentamicin after subconjunctival and retrobulbar injection in the rabbit.

Authors:  M Barza; A Kane; J L Baum
Journal:  Am J Ophthalmol       Date:  1977-03       Impact factor: 5.258

5.  Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluid. Implications for therapy of gram-negative bacillary meningitis.

Authors:  S H Landesman; M L Corrado; C C Cherubin; M Gombert; D Cleri
Journal:  Am J Med       Date:  1980-07       Impact factor: 4.965

6.  Radioactive and bioassay of intraocular antibiotics: double-assay technique to compare penicillin G, cefamandole, and gentamicin in ocular tissues in vivo.

Authors:  P Young; M Barza; A Kane; J Baum
Journal:  Arch Ophthalmol       Date:  1979-04

7.  Comparative susceptibilities of Pseudomonas aeruginosa to 1-oxacephalosporin (LY 127935) and eight other antipseudomonal antimicrobial agents (old and new).

Authors:  V L Yu; R M Vickers; J J Zuravleff
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

8.  Treatment of experimental Haemophilus influenzae type b meningitis with 1-oxa-beta-lactam (LY127935).

Authors:  C S Cordera; R S Pekarek
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

9.  Oxacillin for bacterial endophthalmitis: subconjunctival, intravenous, both, or neither?

Authors:  M Barza; A Kane; J Baum
Journal:  Invest Ophthalmol Vis Sci       Date:  1980-11       Impact factor: 4.799

10.  In vitro activity of LY127935.

Authors:  M Barza; F P Tally; N V Jacobus; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

View more
  2 in total

1.  Pharmacokinetics of aztreonam in rabbit eyes.

Authors:  M Barza; M McCue
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

Review 2.  Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; J A Romankiewicz; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-10       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.